NR4A1 and breast carcinoma: Further studies have shown that the expression of IDO1 was correlated with the expression of CD4, CD3, and CD8 as well as prognosis in colon cancer [32], but the expression of IDO1 was not related to the expression of CD3 and CD8 in the hormone receptor-positive breast cancer [33].